Printer Friendly

INFRASONICS ANNOUNCES FDA APPROVAL FOR NEW VENTILATOR

 SAN DIEGO, Nov. 24 ~PRNewswire~ -- Infrasonics (NASDAQ-NMS: IFRA) announced today that it has received U.S. Food and Drug Administration (FDA) permission to begin marketing a new infant transport ventilator (respirator) to be named the Infant Star Model 100.
 Jim Hitchin, Infrasonics' president, said, "Some babies that are born prematurely in rural communities must be transported to major central city hospitals to treat their underlying diseases. Many have an underlying lung disease that requires a ventilator to help them breathe during the transport. The new Model 100 Infant Star is battery operated, uses very little air~oxygen, can ventilate larger children who have had a life-threatening incident, and is compact enough to fit inside transport incubators for ambulances, helicopters and fixed-winged aircraft.
 "This is a new product area for us that enhances our reputation in the respiratory field and fits very nicely with our distribution organization. We are looking forward to the Model 100 Infant Star adding a greater depth to our revenue and profits."
 Infrasonics is a public company with its common shares traded over the counter under the NASDAQ symbol IFRA. The company manufactures infant incubators and ventilators (respirators) for infants, children and adults, as well as other respiratory-care products for use in hospitals and the home.
 -0- 11~24~92
 ~CONTACT: Jim Hitchin of Infrasonics, 619-450-9898~
 (IFRA)


CO: Infrasonics Inc. ST: California IN: HEA SU: PDT

BP-LS -- SD001 -- 0872 11~24~92 08:02 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 24, 1992
Words:238
Previous Article:DEB SHOPS, INC. REPORTS SALES AND NET INCOME FOR NINE MONTHS AND THIRD QUARTER
Next Article:BWIP HOLDING INC. COMPLETES SECONDARY OFFERING OF CLASS A COMMON STOCK
Topics:


Related Articles
INFRASONICS ANNOUNCES FDA APPROVAL FOR NEW VENTILATOR TECHNIQUE
INFRASONICS COMPLETES PURCHASE OF PREEMICARE CORP.
INFRASONICS SIGNS AGREEMENT FOR PURCHASE OF PREEMICARE CORP.
INFRASONICS ANNOUNCES RECORD SALES AND PROFIT FOR YEAR
FDA APPROVAL RECEIVED FOR NEW VENTILATOR MODALITY
INFRASONICS COMPLETES PURCHASE OF ADVANCED PULMONARY TECHNOLOGIES INC.
INFRASONICS ANNOUNCES FDA APPROVAL TO BEGIN MANUFACTURING AT NEW FACILITY
INFRASONICS ANNOUNCES NEW DIRECTOR

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters